Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Active not recruiting × Interventional × Breast Neoplasm Female × Clear all

Phase

Status

Completed 8 Unknown 6 Recruiting 6 Terminated 1 Not yet recruiting 1 Active not recruiting 1

Sponsor Class

Study Type

Observational 1 Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 622 Carcinoma, Non-Small-Cell Lung 423 Prostatic Neoplasms 373 Neoplasms 332 Multiple Myeloma 238 Colorectal Neoplasms 232 Lung Neoplasms 214 Neoplasm Metastasis 203 Melanoma 198 Ovarian Neoplasms 173 Leukemia, Myeloid, Acute 171 Pancreatic Neoplasms 169 Squamous Cell Carcinoma of Head and Neck 146 Recurrence 139 Glioblastoma 135 Lymphoma 132 Lymphoma, Non-Hodgkin 126 Carcinoma, Renal Cell 123 Stomach Neoplasms 116 Brain Neoplasms 115 Triple Negative Breast Neoplasms 112 Leukemia, Lymphocytic, Chronic, B-Cell 112 Head and Neck Neoplasms 111 Precursor Cell Lymphoblastic Leukemia-Lymphoma 107 Lymphoma, Large B-Cell, Diffuse 102 Carcinoma, Hepatocellular 102 Urinary Bladder Neoplasms 95 Sarcoma 95 Uterine Cervical Neoplasms 91 Colonic Neoplasms 88

Interventions

venetoclax 1 palbociclib 1 Letrozole 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03900884 2024-11-07

PALVEN

Peter MacCallum Cancer Centre, Australia

Phase 1 Active not recruiting

Breast Neoplasm Female

Data powered by HemOnc (CC BY 4.0) Colophon ⚡